spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online May 28, 2004
doi: 10.1242/10.1242/jcs.01245


Journal of Cell Science 117, 2631-2639 (2004)
Published by The Company of Biologists 2004
This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rescher, U.
Right arrow Articles by Gerke, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rescher, U.
Right arrow Articles by Gerke, V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Annexins – unique membrane binding proteins with diverse functions

Ursula Rescher and Volker Gerke*

Institute of Medical Biochemistry, Center for Molecular Biology of Inflammation, University of Münster, von-Esmarch-Str. 56, Münster 48149, Germany



View larger version (25K):

[in a new window]
 
Fig. 1. Molecular structure of annexin A1. Ribbon presentation showing the three-dimensional fold of the C{alpha} backbone of annexin A1 in the presence (left) or absence (right) of Ca2+ ions (Rosengarth et al., 2001Go; Rosengarth and Luecke, 2003Go). The N-terminal domain (residues 1-40) is disordered in the X-ray structure of the Ca2+-bound annexin A1 and integrates into repeat 3 of the folded core domain in the Ca2+-free protein (depicted in yellow in the right-hand structure). Thus, upon Ca2+ binding, the N-terminal {alpha} helix is expelled from the protein core and most likely becomes accessible for other interactions (Rosengarth and Luecke, 2003Go). In the Ca2+-bound conformation, the annexin can attach to membranes through its convex (upper) side, with the Ca2+ ions serving a bridging function. Figure kindly provided by Anja Rosengarth (University of California, Irvine).

 


View larger version (21K):

[in a new window]
 
Fig. 2. Model of membrane domain stabilization mediated by annexin A2. The model takes into account the Ca2+-dependent binding of annexin-A2–S100A10 to acidic phospholipids, which is mediated through the annexin core domain (left). Lateral diffusion could then direct the complex to raft membrane domains rich in cholesterol, glycosphingolipids and certain phosphatidylinositol phosphates, in particular phosphatidylinositol (4,5)-bisphosphate [PtdIns(4,5)P2]. This could result in an annexin-A2–S100A10 fraction not requiring external Ca2+ for raft lipid binding. Following this raft recruitment, lateral annexin-annexin interactions, possibly regulated by Ca2+, could lead to the formation of a protein scaffold beneath the membrane and the concomitant clustering of rafts and recruitment of F-actin.

 


View larger version (19K):

[in a new window]
 
Fig. 3. Potential role of annexin-A2–S100A10 in the transport of plasma membrane channels. Plasma membrane ion channels containing a binding site for S100A10 (e.g. the Ca2+ channel TRPV5 or the sodium channel Nav 1.8) can be directed to the cell surface through a S100A10-mediated interaction with the annexin-A2–S100A10 complex and subsequent membrane binding of the annexin A2 subunits of the complex. This could occur within the biosynthetic pathway or upon recycling of the channels through an endosomal recycling organelle.

 


View larger version (22K):

[in a new window]
 
Fig. 4. Inhibition of leukocyte extravasation by annexin A1. Directed leukocyte transmigration through activated endothelium (red) into inflamed/infected tissue is mediated by chemoattractant receptors of the FPR family, which are targets of fMLF (left). This directed migration is inhibited in the presence of extracellular annexin A1 and/or N-terminal annexin A1 peptides, which are probably generated at sites of inflammation (right). An interaction of annexin A1 with FPR/FPRLs present on migrating leukocytes can trigger receptor desensitization and/or L-selectin shedding, leading to the observed block in directed leukocyte migration.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




© The Company of Biologists Ltd 2004